Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S ...

Recovering erections grabs the attention of most men and their doctors after prostate cancer treatment. A new study redirects ...

breakthrough medication for patients with advanced prostate cancer that has spread to other parts of the body. The medication could be life-changing for many patients in Louisiana, where prostate ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...